Estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 status in invasive breast cancer: a 3,198 cases study at National Cancer Center, China-Reference-Cited by-同舟云学术

Estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 status in invasive breast cancer: a 3,198 cases study at National Cancer Center, China

Published:2014-09-19 Issue:3 Volume:147 Page:551-555
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Zhu Xinxin,Ying Jianming,Wang Fang,Wang Jie,Yang Hongying

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-014-3136-y.pdf

Reference21 articles.

1. Akarolo-Anthony SN, Ogundiran TO, Adebamowo CA (2010) Emerging breast cancer epidemic: evidence from Africa. Breast Cancer Res 12(Suppl 4):S8

2. Singh R, Gupta S, Pawar SB, Pawar RS, Gandham SV, Prabhudesai S (2014) Evaluation of ER, PR and HER-2 receptor expression in breast cancer patients presenting to a semi urban cancer centre in Western India. J Cancer Res Ther 10(1):26–28

3. Harvey JM, Clark GM, Osborne CK, Allred DC (1999) Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol 17(5):1474–1481

4. Raji A, Lurie RH (2007) Human epidermal growth factor receptor 2 testing recommendation. Arch Pathol Lab Med 131(9):1330–1331; author reply 1331–1333

5. Zhou XL, Fan W, Yang G, Yu MX (2014) The clinical significance of PR, ER, NF-kappa B, and TNF-alpha in breast cancer. Dis Markers 2014:494581

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breast carcinoma in the Democratic Republic of the Congo: Characterization of hormone receptors;Current Cancer Reports;2024-03-26

2. Association between Homologous Recombination Repair Defect Status and Long-Term Prognosis of Early HER2-Low Breast Cancer: A Retrospective Cohort Study;The Oncologist;2024-02-16

3. The diagnostic performance of dual-layer spectral detector CT for distinguishing breast cancer biomarker expression and molecular subtypes;Scientific Reports;2024-01-17

4. Differentiating Primary and Recurrent Lesions in Patients with a History of Breast Cancer: A Comprehensive Review;GALEN MED J;2024

5. Research Progress of PD-1/PD-L1 Expression and Its Relationship with Ultrasound Features in Breast Cancer;Advances in Clinical Medicine;2024